Melanoma (stage III or IV) - ipilimumab: final appraisal determination guidance

Melanoma (stage III or IV) - ipilimumab: final appraisal determination guidance

Melanoma (stage III or IV) - ipilimumab: final appraisal determination guidance
02 November 2012
(285.48 Kb 23 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 31 October 2012